Tag: NASDAQ: ADIL

Business

Adial Pharmaceuticals Inc (NASDAQ: ADIL) Is In The Russell Microcap® Index And Seelos Therapeutics Inc (NASDAQ: SEEL) Is In the Russell 2000®, Russell 3000® and Russell Microcap® Indexes

Adial Pharmaceuticals Inc (NASDAQ: ADIL) has found a place in the Russell Microcap® Index. Likewise, Seelos Therapeutics Inc (NASDAQ: SEEL) has confirmed that the company found a place in the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes. The inclusion of both the companies comes as part of the 2021 […]

Business

Adial Pharmaceuticals Inc (NASDAQ: ADIL) Affords Governing and Progress Apprise

Adial Pharmaceuticals Inc (NASDAQ: ADIL) today announced that it had obtained correspondence related to its application for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its medicine candidate, AD04. The candidate will be used to cure Alcohol Use Disorder (AUD) in pediatric patients and adult patients […]

Business

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) Jumps 21% Following Grant of Patent Notice For Genetic Diagnostic Panel

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) jumped 21.19%  after the company announced plans to foray into the genetic testing market following the grant of a Notice of Allowance from the US patent and Trademark Office (USPTO).  Adial receives a patent related to AD04 The patent notice is related to using the […]